The National Institute for Health and Clinical Excellence (NICE) has published guidance accepting varenicline (Champix®) for use on the NHS in England and Wales.
The appraisal contains the following two recommendations:
- Varenicline is recommended within its licensed indications as an option for smokers who have expressed a desire to quit smoking
- Varenicline should normally be prescribed only as part of a programme of behavioural support
Action: Clinicians should be aware of and implement the recommendations made by NICE. Varenicline is an option along with nicotine replacement therapy and bupropion.
|« MHRA launches Drug Safety Update||Government to renegotiate PPRS »|